RAB22A and breast carcinoma: Rab22A overexpression is detected in primary breast tumours and associated with decreased overall and metastasis‐free survival (Wang et al., 2014) whereas Rab22A knockdown impairs breast cancer metastasis in an orthotopic mouse model.